Dr. Venugopal Murugapillai, Ph.D

Since 2009, Dr. M. Venu having a visionary guidance has led to several innovations for Venbiotech (P) Ltd., Managing the manufacturing facility and Biotech teams with having more than (32+) years of experience in deviating from synthetic drugs towards the natural drugs combinations and taking care to provide quality natural products process validation, quality control etc., in helping the healthcare domain with his knowledge and his experience servers as a guiding force for the company. Further Building (Public, Private and Partnership) model to facilitate the following: Raw material banking of medicinal herbs. Creating high tech common biotech research testing facilities to test the active particle ingredients from the raw materials and finished products. Research and product development focus towards human clinical trials works in curing metabloic disorders using the native Indian oriental medicines and related natural product in curing various metabolic disorders.

Dr. Vinodh Kumar Radhakrishnan, Mphil,Ph.D

Dr. Vinodh Kumar (VIN) Radhakrishnan currently working as Senior Lead Scientist for Molecular Medicine & Bioinformatics, VENBIOTECH, Chennai, INDIA. Past 14+ years working experience at City of Hope National Medical Center, Loma Linda University, California, USA. Both are National Cancer Institute (NCI) designated cancer center at department of Molecular Medicine, CA, USA, under top scientific teams and gained hope in translating the bench side research to clinical trials. Expertise in Genome variant analysis pertaining to Human genome sequencing and OMICS focus related to human Cancers and Metabolic Disorder. Specialized research on, Growth Hormones Epigenetics, Triple Negative Breast Cancer, Lung Cancer, Methylation, Mitochondrial disorders towards Diagnostics and Drug discoveries. Trained B-Tech, M-Tech, and MD/PhD students towards precision and personalized medicine.

Early phase of PhD research, worked and collaborated with top South Korean Universities with International Brain Korea 21 fellowships in performing PhD research on Molecular aspects of Lung Cancer, Leukemia and Histone Deacetylase Treatments and further research on natural compound screenings for human Metabolic disorders. He is molecular oncologist pursuing towards Precision & Personalized Medicine in curing Metabolic Disorders: believes in bringing right drug for the right patient at the right time is the mantra, using early diagnostic and preventive approaches to bring health care systems to a next new level of safety, affordability in making treatments accessible to all patients worldwide.